Cargando…
晚期非小细胞肺癌靶向治疗进展与展望：聚焦小分子酪氨酸激酶抑制剂
At present the treatment of advanced non-small cell lung cancer enters a targeted era and develops rapidly. New drugs appear constantly. Small molecular tyrosine kinase inhibitors have occupied the biggest piece of the territory, which commonly have a clear biomarker as predictor, and show remarkabl...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999678/ https://www.ncbi.nlm.nih.gov/pubmed/28442018 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.09 |